Evidence map›Paper›PMID 28838174›Full record

ArticleThe Journal of infectious diseases2017

Polio Endgame: Lessons Learned From the Immunization Systems Management Group.

Simona Zipursky, Jos Vandelaer, Alan Brooks, Vance Dietz, Tasleem Kachra, Margaret Farrell, Ann Ottosen, John L Sever, Michel J Zaffran

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Simona ZipurskyWorld Health Organization, Geneva, Switzerland.
Jos VandelaerUNICEF Programme Division, New York, New York.
Alan BrooksGavi, the Vaccine Alliance, Geneva, Switzerland.
Vance DietzUS Centers for Disease Control and Prevention, Atlanta, Georgia.
Tasleem KachraBill & Melinda Gates Foundation, Seattle, Washington.
Margaret FarrellUNICEF Programme Division, New York, New York.
Ann OttosenUNICEF Supply Division, Copenhagen, Denmark.
John L SeverRotary International, Evanston, Illinois.
Michel J ZaffranWorld Health Organization, Geneva, Switzerland.
United Nations Children's Fund · USWorld Health Organization · CHBill & Melinda Gates Foundation · USCenters for Disease Control and Prevention · USGavi · CHRotary International · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

The Immunization Systems Management Group (IMG) was established to coordinate and oversee objective 2 of the Polio Eradication and Endgame Strategic Plan 2013-2018, namely, (1) introduction of ≥1 dose of inactivated poliovirus vaccine in all 126 countries using oral poliovirus vaccine (OPV) only as of 2012, (2) full withdrawal of OPV, starting with the withdrawal of its type 2 component, and (3) using polio assets to strengthen immunization systems in 10 priority countries. The IMG's inclusive, transparent, and partnership-focused approach proved an effective means of leveraging the comparative and complementary strengths of each IMG member agency. This article outlines 10 key factors behind the IMG's success, providing a potential set of guiding principles for the establishment and implementation of other interagency collaborations and initiatives beyond the polio sphere.

Indexed as

Disease EradicationGlobal HealthImmunization ProgramsHumansOrganizational ObjectivesPoliomyelitisPoliovirus Vaccine, InactivatedPoliovirus Vaccine, OralPoliovirus Vaccine, InactivatedPoliovirus Vaccine, Oralendgameinactivated polio vaccineIPVOPVoral polio vaccinepoliopolio eradicationroutine immunizationvaccines

Identifiers

PMID28838174
PMCPMC5853539
OpenAlexW2734914523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.